Use of mammalian target of rapamycin (mTOR) with reduced tacrolimus in kidney transplant recipients led to an increase in circulating CD4 + CD25 high CD127 − CD45RA − activated Tregs, and there was a nonsignificant trend toward improved graft function [ 33 ].
← all excerpts
Evaluating Activated Regulatory T Cells as a Biomarker of Chronic Allograft Inflammation in Pediatric Kidney Transplant Recipients.
1
—
—